Clinical trial
Reduce Driveline Trauma Through Stabilization and Exit Site Management (RESIST) Pilot Study Protocol
NCT01485666 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reduce Driveline Trauma Through Stabilization and Exit Site Management (RESIST) Pilot Study Protocol
- Lead sponsor
- Abbott Medical Devices
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2012
- Completion date
- August 31, 2013
- Enrollment
- 50 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
left ventricular assist device, percutaneous lead management